Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis
European Respiratory Journal · 2023
DOI: 10.1183/13993003.01799-2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2023. Verfasst von Xiuju Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Pulmonary fibrosis is a common and severe fibrotic lung disease with high morbidity and mortality. Recent studies have reported a large number of unwanted myofibroblasts appearing in pulmonary fibrosis, and shown that the sustained activation of myofibroblasts is essential for unremitting interstitial fibrogenesis. However, the origin of these myofibroblasts remains poorly understood. Here, we create new mouse models of pulmonary fibrosis and identify a previously unknown population of endothelial cell (EC)-like myofibroblasts in normal lung tissue. We show that these EC-like myofibroblasts significantly contribute myofibroblasts to pulmonary fibrosis, which is confirmed by single-cell RNA sequencing of human pulmonary fibrosis. Using the transcriptional profiles, we identified a small molecule that redirects the differentiation of EC-like myofibroblasts and reduces pulmonary fibrosis in our mouse models. Our study reveals the mechanistic underpinnings of the differentiation of EC-like myofibroblasts in pulmonary fibrosis and may provide new strategies for therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- These authors contributed equally to this work.
- Department of Pediatrics, Stanford University, Stanford, CA, USA.
- Division of Pulmonary and Critical Care Medicine, Clinical Immunology, and Allergy, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- The Molecular Biology Institute at UCLA, Los Angeles, CA, USA.
- Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA yyao@mednet.ucla.edu.
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Wu, X., Zhang, D., Qiao, X., Zhang, L., Cai, X., Ji, J., Ma, J. A., Zhao, Y., Belperio, J. A., Boström, K. I., & Yao, Y. (2023). Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis. European Respiratory Journal. https://doi.org/10.1183/13993003.01799-2022
Vancouver
Wu X, Zhang D, Qiao X, Zhang L, Cai X, Ji J, et al. Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis. European Respiratory Journal. 2023. doi:10.1183/13993003.01799-2022
BibTeX
@article{Wu2023,
author = {Wu, Xiuju and Zhang, Daoqin and Qiao, Xiaojing and Zhang, Li and Cai, Xinjiang and Ji, Jaden and Ma, Jocelyn A and Zhao, Yan and Belperio, John A and Boström, Kristina I and Yao, Yucheng},
title = {Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis},
journal = {European Respiratory Journal},
year = {2023},
doi = {10.1183/13993003.01799-2022}
}
EUVIMED